1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US Hydrocephalus Shunts Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US Hydrocephalus Shunts Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising incidence of neurological disorders
- 5.1.3 Increased demand for minimally invasive devices
- 5.1.4 Growth in pediatric healthcare
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Expansion in adjustable shunt technology
- 5.2.3 Demand for antimicrobial-coated shunts
- 5.2.4 Growth in at-home patient monitoring
5.3 Future Trends
- 5.3.1
- 5.3.2 Focus on MRI-compatible shunt designs
- 5.3.3 Development of smart, pressure-regulating shunts
- 5.3.4 Increased use in patient-specific solutions
5.4 Impact of Drivers and Restraints
6. US Hydrocephalus Shunts Market Country Analysis
6.1 US Hydrocephalus Shunts Market Overview
6.2 US Hydrocephalus Shunts Market Revenue 2020-2030 (US$ Million)
6.3 US Hydrocephalus Shunts Market Forecast Analysis
7. US Hydrocephalus Shunts Market Analysis – by Product
7.1 Hydrocephalus Valves
- 7.1.1 Overview
- 7.1.2 Hydrocephalus Valves: US Hydrocephalus Shunts Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hydrocephalus Catheters
- 7.2.1 Overview
- 7.2.2 Hydrocephalus Catheters: US Hydrocephalus Shunts Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Neuronavigation Systems
- 7.3.1 Overview
- 7.3.2 Neuronavigation Systems: US Hydrocephalus Shunts Market – Revenue and Forecast to 2031 (US$ Million)
8. US Hydrocephalus Shunts Market Analysis – by Type
8.1 Ventriculoperitoneal
- 8.1.1 Overview
- 8.1.2 Ventriculoperitoneal: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Ventriculoatrial
- 8.2.1 Overview
- 8.2.2 Ventriculoatrial: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Ventriculopleural
- 8.3.1 Overview
- 8.3.2 Ventriculopleural: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Lumboperitoneal
- 8.4.1 Overview
- 8.4.2 Lumboperitoneal: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
9. US Hydrocephalus Shunts Market Analysis – by Age Group
9.1 Pediatric
- 9.1.1 Overview
- 9.1.2 Lumboperitoneal: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Adults
- 9.2.1 Overview
- 9.2.2 Lumboperitoneal: US Hydrocephalus Shunts Market – Revenue and Forecast to 2030 (US$ Million)
10. US Hydrocephalus Shunts Market – United States Analysis
10.1 United States
- 10.1.1 United States: US Hydrocephalus Shunts Market – Revenue
and Forecast to 2030 (US$ Million)
- 10.1.1.1 United States:
US Hydrocephalus Shunts Market Breakdown, by Product
- 10.1.1.2 United States:
US Hydrocephalus Shunts Market Breakdown, by Type
- 10.1.1.3 United States:
US Hydrocephalus Shunts Market Breakdown, by Age Group
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. US Hydrocephalus Shunts Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 B. Braun SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sophysa SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Integra LifeSciences Holdings Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 KANEKA MEDIX CORP.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Medtronic Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Natus Medical Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Anuncia Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Desu Medical
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights